| Human Immunodeficiency Virus |
NCT05213689: HIV Self-Testing and Comic Intervention With Refugee Adolescents and Youth |
|
|
| Not yet recruiting | N/A | 120 | Canada | Educational comic book, HIV Self-testing | University of Toronto, ViiV Healthcare | HIV/AIDS, HIV Infections, Knowledge, Attitudes, Practice | 09/22 | 10/22 | | |
NCT04135443: Evaluation of 3T, a Sex-Positive HIV/STI Mobile App Intervention for Young Black Men Ages 14-19 Attracted to Men |
|
|
| Recruiting | N/A | 250 | US | 3T Tune in! Turn on! Turn up!, General Health App | ETR Associates, Dfusion Inc. | HIV/AIDS and Infections, Sexual Behavior, Health Knowledge, Attitudes, Practice | 10/22 | 11/22 | | |
NCT04151498: HIV Reengagement and Assessment Mobile Program (Project RAMP) |
|
|
| Completed | N/A | 30 | US | Reengagement and Assessment Mobile Program, Project RAMP, Qualitative Interview | University of North Carolina, Chapel Hill, ViiV Healthcare | HIV/AIDS | 11/22 | 04/23 | | |
| Completed | N/A | 120 | Europe | Integrase strand transfer inhibitors | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal, Merck Sharp & Dohme LLC | HIV Infections | 12/22 | 03/23 | | |
NCT03194880: Alere COMBO and Alere q Detect in an HIV PrEP Program in Thailand |
|
|
| Completed | N/A | 150 | RoW | AlereCOMBO and Alere q Detect | Thai Red Cross AIDS Research Centre, Alere, Inc. | HIV | 12/22 | 02/23 | | |
NCT04125784: Lipid Profile and Diabetes Mellitus in People With HIV |
|
|
| Completed | N/A | 450 | Europe | | Moritz Oberndorfer, Merck Gesellschaft mbH, Austria | HIV Infections, Dyslipidemias, Diabetes Mellitus, Cardiovascular Risk Factor | 12/22 | 02/23 | | |
NCT04194021: Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir |
|
|
| Active, not recruiting | N/A | 871 | RoW | | Elizabeth Glaser Pediatric AIDS Foundation, Janssen, LP | HIV/AIDS | 12/22 | 12/23 | | |
NCT04782739: Impact of COVID-19 on Provision and Uptake of Prevention of Mother-to-child Transmission of HIV Services in Zimbabwe |
|
|
| Completed | N/A | 30 | RoW | None - Descriptive study | University of Zimbabwe, Ministry of Health and Child Welfare, Zimbabwe, Centre for Sexual Health and HIV/AIDS Research Zimbabwe (CeSHHAR Zimbabwe), PENTA Foundation, ViiV Healthcare, University College, London | HIV Infections, Syphilis | 12/22 | 12/22 | | |
NCT04930614: Prevalence and Risk Factors of HIV Infections in Transgender and Non-binary People in Flanders and Brussels (Belgium) |
|
|
| Completed | N/A | 1068 | Europe | Survey on socio-demographic variables and healthcare-seeking, sexual and drug-using behaviour | Centre for Evidence-Based Practice, Belgium, University Hospital, Ghent, Institute of Tropical Medicine, Belgium, Institute for the Equality of Women and Men, Belgium, Gilead Sciences, Belgian Red Cross | HIV Infections | 07/23 | 07/23 | | |
NCT04495348: Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance |
|
|
| Completed | N/A | 18 | US | Doravirine | University of Colorado, Denver, Gilead Sciences | HIV-1-infection, Weight Gain | 01/23 | 06/23 | | |
COMBINE-2, NCT04019873: '': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor |
|
|
| Completed | N/A | 1 | Europe | Dolutegravir (DTG), Lamivudine (3TC), Rilpivirine (RPV) | ViiV Healthcare | HIV Infections | 01/23 | 01/23 | | |
NCT05495204: External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA |
|
|
| Completed | N/A | 141 | US | Ibalizumab, Regimens not containing ibalizumab | Epividian, Theratechnologies, FIECON | HIV-1-infection | 02/23 | 02/23 | | |
NCT05044286: Longer-Acting PrEP in Transgender and Gender Diverse Texans |
|
|
| Completed | N/A | 565 | US | no intervention | University of Texas at Austin, Texas Health Institute, Merck Sharp & Dohme LLC, Transgender Education Network of Texas | HIV-1-infection | 01/23 | 08/23 | | |
DrEW, NCT05421806: A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/ |
|
|
| Completed | N/A | 399 | Europe | | NEAT ID Foundation, Merck Sharp & Dohme LLC | HIV I Infection | 02/23 | 08/23 | | |
NCT05222945: A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide |
|
|
| Not yet recruiting | N/A | 34 | Europe | Biopsies and bloood samplings | ANRS, Emerging Infectious Diseases, Gilead Sciences | HIV-1-infection | 03/23 | 03/24 | | |
| Completed | N/A | 25 | US | CAB-RPV LA, Cabotegravir-Rilpivirine Long Acting, Standard treatment within an HIV clinic | Boston Medical Center, ViiV Healthcare | HIV Infections | 03/23 | 03/23 | | |
HIV CoCo, NCT05481216: HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV |
|
|
| Completed | N/A | 2598 | Europe | COVID-19, HIV-1 infection | NEAT ID Foundation, Gilead Sciences | HIV-1-infection, COVID-19 | 03/23 | 08/23 | | |
| Completed | N/A | 100 | US | EPIC-P | University of Connecticut, Gilead Sciences | HIV | 04/23 | 04/23 | | |
NCT03564613: Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women |
|
|
| Recruiting | N/A | 250 | Europe | DTG | ViiV Healthcare | HIV Infections | 10/24 | 10/24 | | |
NCT05383755: Digital Intervention to Address Stigma Among Pregnant Adolescents Living With HIV |
|
|
| Active, not recruiting | N/A | 198 | RoW | Digital intervention for pregnant adolescents living with HIV | Pacific Institute for Research and Evaluation, Fogarty International Center of the National Institute of Health, Kenya Medical Research Institute, 3-C Institute for Social Development | Mother to Child Transmission, Pregnancy in Adolescence, Social Stigma, Self Disclosure, HIV | 01/24 | 05/24 | | |
JUNGLE, NCT03518060: Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1 |
|
|
| Completed | N/A | 200 | Europe | Juluca | ViiV Healthcare, MUC Research GmbH | HIV Infections | 05/23 | 05/23 | | |
DISCO, NCT04066036: Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa |
|
|
| Completed | N/A | 1000 | RoW | This is an observational study only. | Massachusetts General Hospital, Africa Health Research Institute, Mbarara University of Science and Technology, National Institute of Allergy and Infectious Diseases (NIAID), Wellcome Trust, ViiV Healthcare, Harvard Medical School (HMS and HSDM), University of KwaZulu, Emory University | HIV-1-infection | 05/23 | 05/23 | | |
NCT05454514: Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS |
|
|
| Completed | N/A | 3 | US | HiDO medication adherence platform, Automated Medication Platform with Video Observation, Time on Task | HiDO Technologies | HIV Infections | 05/23 | 05/23 | | |
| Completed | N/A | 8 | US | Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose tissue biopsy, MRI scan to assess intrahepatic triglyceride content | Washington University School of Medicine, Janssen Scientific Affairs, LLC | HIV I Infection, Adiposity | 06/23 | 06/23 | | |
DOLUVOIR, NCT04133012: Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone |
|
|
| Completed | N/A | 20 | Europe | Samplings | ANRS, Emerging Infectious Diseases, ViiV Healthcare | HIV-1 Infection | 06/23 | 06/23 | | |
NCT02822495: Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies |
|
|
| No Longer Available | N/A | | NA | tabelecleucel, tab-cel®, ATA129, EBV-CTL | Atara Biotherapeutics | Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma, EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Epstein-Barr Viremia, Lymphoma, AIDS-related, Epstein-Barr Virus-associated Lymphoproliferative Disease (EBV+ LPD) With Primary Immunodeficiency (PID), Leiomyosarcoma (LMS), Nasopharyngeal Carcinoma (NPC), Epstein-Barr Virus-associated Lymphoproliferative Disease (EBV+ LPD) With Acquired Immunodeficiency (AID), Solid Organ Transplant Complications, Stem Cell Transplant Complications | | | | |
Afya 2 Phase2, NCT04201353: Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy Phase II |
|
|
| Active, not recruiting | N/A | 1984 | RoW | Conditional Cash Transfer | University of California, Berkeley, Health for a Prosperous Nation, Rasello, Tanzania Ministry of Health, Community Development, Gender, Elderly and Children | HIV (Human Immunodeficiency Virus) | 11/23 | 06/24 | | |
URBAN, NCT03754803: Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany |
|
|
| Active, not recruiting | N/A | 300 | Europe | HIV Symptom Distress Module Questionnaire, HIV treatment satisfaction questionnaire | ViiV Healthcare, MUC Research GmbH | HIV Infections | 07/23 | 02/24 | | |
| Recruiting | N/A | 501 | RoW | HIV-1 plasma RNA Genotyping secuencing by Sanger technique, Sanger Sequencing, HIV-1 plasma RNA Genotyping secuencing by Ultra-deep sequencing technique, Next-Generation Sequencing | Fundacion REVIVA, Red de VIH del Valle del Cauca, ViiV Healthcare, Centro de Investigación en. Enfermedades Infecciosas, Mexico | HIV Infection | 07/23 | 09/23 | | |
NCT05064020: Bictegravir in the Elderly Living With HIV (BICEP) |
|
|
| Active, not recruiting | N/A | 162 | US | Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY], Biktarvy, BIC/FTC/TAF | State University of New York at Buffalo, Gilead Sciences | HIV-1-infection | 12/24 | 12/24 | | |
NCT05418790: A Pilot Study to Evaluate Alternative Viral Load Tests During Start of Antiretroviral Therapy |
|
|
| Not yet recruiting | N/A | 15 | NA | TASSO device | Luis Montaner, Merck Sharp & Dohme LLC | HIV-1-infection | 08/23 | 09/23 | | |
| Completed | N/A | 69 | US | Virtual clinical visits with home lab kits and mailed HIV PrEP | University of Colorado, Denver, Gilead Sciences | HIV Infections, Sexually Transmitted Infections | 07/23 | 07/23 | | |
LAI-ART, NCT05152953: Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy |
|
|
| Completed | N/A | 63 | US | | University of California, San Francisco, ViiV Healthcare, Texas A&M University, Auburn University, Nova Southeastern University | Hiv | 11/23 | 11/23 | | |
| Completed | N/A | 468 | RoW | SPIRIT Intervention | University of California, San Francisco, Makerere University, National Institute of Allergy and Infectious Diseases (NIAID), Cipla Ltd. | Tuberculosis, HIV/AIDS | 11/23 | 11/23 | | |
TEAMH, NCT03387397: Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities |
|
|
| Completed | N/A | 170 | US | | Northwell Health, Gilead Sciences | HIV Infection Primary | 09/23 | 09/23 | | |
| Completed | N/A | 250 | RoW | Blood sampling | Institut Pasteur, National Institute of Hygiene and Epidemiology - Vietnam (NIHE) | HIV Infections | 10/23 | 10/23 | | |
| Recruiting | N/A | 100 | US | TelePrEP | University of Colorado, Denver, Gilead Sciences | Hiv | 03/25 | 04/25 | | |
COMEBACK, NCT04519970: Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key |
|
|
| Active, not recruiting | N/A | 100 | US | Case Management | Gregory Huhn, Gilead Sciences | Hiv | 10/23 | 04/24 | | |
| Recruiting | N/A | 175 | US | Individualized Feedback | Columbia University, Merck Sharp & Dohme Corp. | HIV Prevention, Pre-exposure Prophylaxis | 10/23 | 10/23 | | |
NCT05794191: A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV |
|
|
| Recruiting | N/A | 1 | US | Vaccine Administration | Pfizer | HIV, Pneumonia, Infections, Pneumococcal | 10/24 | 10/24 | | |
NCT04754139: A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population |
|
|
| Active, not recruiting | N/A | 1200 | RoW | WeChat mobile mini-application | University of Chicago, Gilead Sciences, Guangzhou 8th People's Hospital, Social Entrepreneurship to Spur Health (SESH), Wuhan University | HIV Preexposure Prophylaxis | 07/24 | 07/24 | | |
| Active, not recruiting | N/A | 567 | RoW | Conditional Cash Transfer | University of California, Berkeley, Health for a Prosperous Nation, Rasello, Management and Development for Health, Ministry of Health, Tanzania, National Institute of Mental Health (NIMH) | HIV (Human Immunodeficiency Virus) | 12/24 | 06/25 | | |
DORASPEP, NCT05761509: "Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk" |
|
|
| Active, not recruiting | N/A | 226 | Europe | Doravirine, Delstrigo®, Pifeltro® | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba, Merck Sharp & Dohme LLC | HIV Infections | 06/24 | 06/24 | | |
NCT05799339: Optimizing CAB-LA as PrEP for Women Who Inject Drugs |
|
|
| Recruiting | N/A | 144 | US | | Alexis Roth, ViiV Healthcare, University of Miami, University of Michigan, Beth Israel Deaconess Medical Center | HIV Infections, Opioid Use, Trauma, Psychological | 12/24 | 12/24 | | |
| Recruiting | N/A | 692 | RoW | PKC (adapted adherence counseling) and Conditional Cash Transfers | University of California, Berkeley, Health for a Prosperous Nation, Rasello, Management and Development for Health, Ministry of Health, Tanzania, National Institute of Mental Health (NIMH) | HIV (Human Immunodeficiency Virus) | 12/24 | 01/25 | | |
| Active, not recruiting | N/A | 816 | Canada | Descovy, emtricitabine 200 mg/tenofovir alafenamide 25 mg | HQ Toronto, Gilead Sciences | HIV Prevention | 11/24 | 11/24 | | |
| Recruiting | N/A | 458 | US | Health service - home-based PrEP monitoring | University of Washington, Tasso Inc. | HIV Prevention, Pre-exposure Prophylaxis, STI | 03/25 | 09/25 | | |
NCT05709860: An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy |
|
|
| Recruiting | N/A | 200 | US | EMC2 PrEP Educational Tool, Discrete Scheduling of a Dedicated PrEP Visit | Northwestern University, Merck Sharp & Dohme LLC | HIV Infections, Electronic Health Record, Primary Health Care | 09/24 | 12/24 | | |
NCT06072443: AURORA Study-A Transformative Approach to Support PrEP Medication Persistence |
|
|
| Recruiting | N/A | 105 | US | Digital Health Companion (mobile App) | WV Health Right, Inc., ViiV Healthcare | HIV Infections | 12/24 | 06/25 | | |
| Completed | N/A | 196 | US | Diagnostic Test, CT Scan, Fibroscan, Urine and Blood testing, HIV Anti-retroviral Background Therapy | Theratechnologies, Dacima Consulting, Medpace, Inc., Vanderbilt University Medical Center, Echosens | HIV, HIV-Infections, HIV-1-infection, HIV I Infection, HIV Lipodystrophy, HIV Infection Primary, HIV-Associated Lipodystrophy, HIV Disease Progression, Lipohypertrophy, Liver Diseases, NAFLD, NASH, Liver Fibrosis, Hepatic Fibrosis, Waist Circumference, BMI, Ectopic Fat, Liver Fat, Hepatic Steatosis | 10/23 | 10/23 | | |
| Recruiting | N/A | 130 | US | Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life | Oregon Research Behavioral Intervention Strategies, Inc., University of Illinois at Chicago | HIV Infection, Sexually Transmitted Infections, Implementation | 04/24 | 05/24 | | |
LiVes-LLC, NCT06144229: Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies |
|
|
| Not yet recruiting | N/A | 810 | US | HPV test using Evalyn Brush | University of California, Los Angeles, Harvard School of Public Health (HSPH), Frontier Science & Technology Research Foundation, Inc., Albert Einstein College of Medicine, Boston Children's Hospital, St. Jude Children's Research Hospital, University of Colorado, Denver, Bronx-Lebanon Hospital Center Health Care System, University of Miami, Baylor College of Medicine, Children's Hospital New Orleans, LA, Jacobi Medical Center, Ann & Robert H Lurie Children's Hospital of Chicago, Westat | Hiv, Hpv | 04/28 | 04/28 | | |
P4P, NCT06353295: Community-based, Peer-delivered PrEP for Female Sex Workers in Rural Uganda: The Peers for PrEP () Study |
|
|
| Recruiting | N/A | 140 | RoW | P4P intervention | University of California, San Francisco, Gilead Sciences | HIV/AIDS | 06/25 | 06/25 | | |
VSS, NCT06181916: Quantitative and Qualitative Research for "mHealth Program to Support People Living With HIV Across the HIV Care Continuum" |
|
|
| Not yet recruiting | N/A | 300 | US | Amp | Sentient Research, AIDS Healthcare Foundation, Los Angeles LGBT Center, University of Mississippi Medical Center, Wayne State University | HIV Infections | 11/24 | 12/24 | | |
| Recruiting | N/A | 200 | Europe | | Chelsea and Westminster NHS Foundation Trust, ViiV Healthcare | HIV Infections, Gender Identity, Human Immunodeficiency Virus | 04/24 | 10/25 | | |
NCT06368453: A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test |
|
|
| Not yet recruiting | N/A | 1700 | NA | INSTI® HIV Self-Test | bioLytical Laboratories | Human Immunodeficiency Virus I Infection, Human Immunodeficiency Virus II Infection | 05/25 | 05/25 | | |
PediacamNEG, NCT06302933: Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms |
|
|
| Recruiting | N/A | 451 | RoW | Blood sampling | ANRS, Emerging Infectious Diseases, Centre Pasteur du Cameroun, Centre Mère et Enfant de la Fondation Chantal Biya, Centre Hospitalier D'essos, Hospital General De Douala, Centre Hospitalier Universitaire d'Orléans, Institut Pasteur, Hopital Universitaire Robert-Debre, Université Paris-Sud | HIV Infections | 08/25 | 08/25 | | |
NCT06402383: Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living With HIV |
|
|
| Not yet recruiting | N/A | 2000 | NA | Vaccination Provision, Vaccination Provision 2 | Queen's University, Merck Canada Inc. | Cervical Cancer | 01/26 | 04/26 | | |
MAGICIEN, NCT06082336: Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C |
|
|
| Recruiting | N/A | 252 | Europe | MagIA IBC test in capillary blood, MagIA IBC test in other matrices | MagIA Diagnostics | Combined Point of Care Diagnostic of HIV, HBV and HCV | 06/24 | 09/24 | | |
BIC-STaR, NCT03580668: Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide |
|
|
| Completed | N/A | 201 | Canada | B/F/TAF, Biktarvy® | Gilead Sciences | HIV-1-infection | 06/24 | 06/24 | | |
| Not yet recruiting | N/A | 15 | NA | TruTag System, Biktarvy Pill | Brigham and Women's Hospital, Trutag Technologies, Gilead Sciences | Hiv, Medication Adherence, Compliance, Medication | 12/24 | 04/25 | | |
| Recruiting | N/A | 55 | US | Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), Feasibility of Intervention Measure (FIM), HIV Stigma Scale Questionnaire, HIV Treatment Satisfaction Questionnaire status version (HIVTSQs12), HIV Treatment Satisfaction Questionnaire change version (HIVTSQc12), Needs and Barriers Assessment, Pre-visit Outreach, Qualitative interview, Staff education | University of Nebraska, ViiV Healthcare | HIV | 04/26 | 04/26 | | |
| Recruiting | N/A | 30 | US | aDOT-CEI, AiCure | University of California, San Francisco, AiCure, RTI International, National Institute of Mental Health (NIMH) | HIV/AIDS, Mobile Health, Young Adults | 07/24 | 07/24 | | |
| Recruiting | N/A | 900 | Europe | Harm reduction of informal PrEP use, PrEP follow up based on point of care testing | BCN Checkpoint, Projecte dels NOMS-Hispanosida (BCN Checkpoint and BCN PrEP·Point), Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | HIV/AIDS, HIV Infections, Sexually Transmitted Diseases, Vaccination, Adherence, Medication, Side Effect of Drug, Preexposure Prophylaxis | 09/24 | 09/24 | | |
| Completed | N/A | 31 | US | Gain framing plus demographically targeted photos, Loss framing plus demographically targeted photos, Gain framing plus not demographically targeted photos, Loss framing plus not demographically targeted photos | University of North Carolina, Chapel Hill, Gilead Sciences | HIV Prevention | 11/23 | 03/24 | | |
| Terminated | N/A | 1 | US | Home visit delivery strategy | University of Arkansas, ViiV Healthcare | HIV-1-infection, Medication Adherence, Satisfaction, Patient | 12/23 | 12/23 | | |
BMS02, NCT04862975: Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana |
|
|
| Recruiting | N/A | 200 | RoW | Dolutegravir, Dolutegravir Sodium, DTG, Lamivudine, 3TC, Emtricitabine, FTC, Tenofovir Disoproxil Fumarate, Tenofovir DF, TDF | Duke University, The Emmes Company, LLC | Lactating Women on Select DOI, Breastmilk Fed Infants of Mothers on Select DOI, HIV Infections | 12/24 | 12/24 | | |
| Recruiting | N/A | 466 | US | I'm Fully Empowered for Her (IFE4Her) | University of North Carolina, Chapel Hill, Gilead Sciences, Duke University | HIV Prevention, Pre-exposure Prophylaxis, PrEP, Prevention, Women's Health, Mobile Health | 12/24 | 12/24 | | |
NCT05979714: The Cheeky Study: A Novel Delivery System for CAB-RPV LA |
|
|
| Recruiting | N/A | 50 | US | Patient-centered injection site, Patient-centered adherence support, Provider education, Improved clinic communication strategies | Public Health Foundation Enterprises, Inc., ViiV Healthcare, San Francisco Department of Public Health, Lyon-Martin Community Health Services | HIV Infections | 12/24 | 12/24 | | |
| Not yet recruiting | N/A | 50 | RoW | | Pontificia Universidad Catolica de Chile, ViiV Healthcare | Patient Satisfaction, Patient Preference, Quality of Life, Acceptability of Health Care | 12/24 | 04/25 | | |
NCT05968755: Leveraging Chatbot to Improve PrEP in the Southern United States |
|
|
| Not yet recruiting | N/A | 145 | US | A chatbot designed to promote PrEP awareness and uptake for Black MSM, General educational messages | Yale University, Gilead Sciences | HIV Prevention, PrEP Awareness, PrEP Uptake | 06/25 | 06/25 | | |
NCT01137981: Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects |
|
|
| Recruiting | N/A | 1 | US | Any Antiretroviral Therapy | ViiV Healthcare, GlaxoSmithKline, Syneos Health | Infection, Human Immunodeficiency Virus, HIV Infections | 12/24 | 12/24 | | |
| Completed | N/A | 1910 | Europe | | Radboud University Medical Center, ViiV Healthcare, Elisabeth-TweeSteden Ziekenhuis, Erasmus Medical Center, Onze Lieve Vrouwe Gasthuis | HIV Infections | 07/23 | 07/23 | | |
HSVHIV, NCT05823779: A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects |
|
|
| Recruiting | N/A | 50 | US | Blood draw | Global Research Institute, Rational Vaccines Inc | HIV Disease, Herpes Simplex 1, Herpes Simplex 2 | 12/24 | 04/25 | | |
NCT05420207: Implantable Long-Acting Pre-Exposure Prophylaxis For MSM |
|
|
| Not yet recruiting | N/A | 70 | US | No intervention | Elizabeth Arnold, Merck Sharp & Dohme LLC, University of Texas at Austin | HIV Prevention | 07/25 | 07/25 | | |
MonVIP, NCT05922735: Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users |
|
|
| Not yet recruiting | N/A | 5000 | NA | Questionnaire | ANRS, Emerging Infectious Diseases, INSERM UMR S 1136, Institut de Recherche en Santé Publique, France, Institut Pasteur | Monkey Pox, HIV Infections | 02/25 | 02/25 | | |
NCT05330923: Effect of NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients |
|
|
| Recruiting | N/A | 200 | RoW | | Peking Union Medical College Hospital, Wuxi Hisky Medical Technology Co Ltd | Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Fibrosis, HIV/AIDS | 05/25 | 01/27 | | |
| Recruiting | N/A | 2800 | RoW | TRI-MOM intervention | Institut de Recherche pour le Developpement, Centre Muraz, Medical Research Council, Institut Pasteur, REVS PLUS Burkina Faso, Young Gambian Mums Fund, National AIDS Control Program Gambia | Hiv, Syphilis, HBV | 05/25 | 05/25 | | |
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab |
|
|
| Recruiting | N/A | 600 | US | No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment | Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research | HIV Infections, Multi-Antiviral Resistance | 06/25 | 12/25 | | |
CREATE, NCT06062979: Clinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in Care |
|
|
| Enrolling by invitation | N/A | 180 | US | rilpivirine/cabotegravir | Whitman-Walker Institute, ViiV Healthcare | HIV | 06/25 | 06/25 | | |
| Active, not recruiting | N/A | 460 | RoW | | ANRS, Emerging Infectious Diseases, Centre Pasteur du Cameroun, Centre Mère et Enfant de la Fondation Chantal Biya, Centre Hospitalier D'essos, Hospital General De Douala, Institut Pasteur, Institut National de la Santé Et de la Recherche Médicale, France, Assistance Publique - Hôpitaux de Paris | HIV | 07/25 | 07/25 | | |
NCT05540964: An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy |
|
|
| Enrolling by invitation | N/A | 7 | US | Antiretroviral Therapy Interruption(ATI) | American Gene Technologies International Inc. | HIV | 07/25 | 07/25 | | |
SAN-BB-01, NCT01931644: At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
|
|
| Completed | N/A | 17667 | US | | Sanguine Biosciences | All Diagnosed Health Conditions, ADD/ADHD, Alopecia Areata, Ankylosing Spondylitis, Asthma, Atopic Dermatitis Eczema, Beta Thalassemia, Bipolar Disorder, Breast Cancer, Celiac Disease, Cervical Cancer, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Colon Cancer, Colorectal Cancer, Crohn's Disease, Cystic Fibrosis, Depression, Diabetes Mellitus, Duchenne Muscular Dystrophy, Endometriosis, Epilepsy, Facioscapulohumeral Muscular Dystrophy, G6PD Deficiency, General Anxiety Disorder, Hepatitis B, Hereditary Hemorrhagic Telangiectasia, HIV/AIDS, Human Papilloma Virus, Huntington's Disease, Idiopathic Thrombocytopenic Purpura, Insomnia, Kidney Cancer, Leukemia, Lung Cancer, Lupus Nephritis, Lymphoma, Melanoma, Multiple Myeloma, Multiple Sclerosis, Myositis, Myotonic Dystrophy, Ovarian Cancer, Pancreatic Cancer, Parkinson's Disease, Polycystic Kidney Diseases, Prostate Cancer, Psoriasis, Psoriatic Arthritis, Rosacea, Scleroderma, Sickle Cell Anemia, Sickle Cell Trait, Sjogren's Syndrome, Skin Cancer, Spinal Muscular Atrophy, Systemic Lupus Erythematosus, Thrombotic Thrombocytopenic Purpura, Trisomy 21, Ulcerative Colitis | 04/24 | 04/24 | | |
| Recruiting | N/A | 250 | US | Team Based Inpatient ARTAS, Standard of Care | Loma Linda University, Gilead Sciences | HIV Infections, Inpatient Facility Diagnoses | 08/25 | 08/25 | | |
| Recruiting | N/A | 125 | US | Cabotegravir Injection, Apretude | Oregon Health and Science University, ViiV Healthcare | HIV/AIDS | 12/25 | 12/25 | | |
NCT04518228: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum |
|
|
| Recruiting | N/A | 325 | US, RoW | Bictegravir (BIC), Tenofovir alafenamide (TAF), Cabotegravir (CAB), Dolutegravir (DTG), Atazanavir/ritonavir (ATV/r), Darunavir/ritonavir (DRV/r), Lopinavir/ritonavir (LPV/r), Cobicistat, Ritonavir, First-Line TB Treatment, Second-Line TB Treatment, Doravirine (DOR) | National Institute of Allergy and Infectious Diseases (NIAID), International Maternal Pediatric Adolescent AIDS Clinical Trials Group, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), Gilead Sciences, ViiV Healthcare, Merck Sharp & Dohme LLC | HIV Infections, Tuberculosis | 03/26 | 03/26 | | |
| Recruiting | N/A | 176 | Europe | | Radboud University Medical Center, PENTA Foundation, Merck Sharp & Dohme LLC, Bristol-Myers Squibb, Janssen Pharmaceutica, ViiV Healthcare, Gilead Sciences | HIV Infections | 12/25 | 12/25 | | |
| Recruiting | N/A | 37853 | Europe, RoW | | Rigshospitalet, Denmark, Gilead Sciences, ViiV Healthcare | HIV | 12/25 | 12/25 | | |
MOVIDA-Hep2, NCT05506475: Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in Vietnam |
|
|
| Not yet recruiting | N/A | 400 | RoW | Blood samples | Institut Pasteur, National Institute of Hygiene and Epidemiology, Vietnam, ANRS, Emerging Infectious Diseases | HIV Infection, Hepatitis C Infection | 04/25 | 04/25 | | |
NCT05090267: The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study |
|
|
| Recruiting | N/A | 80 | US | Probiotic Supplement, Transcutaneous Vagal Nerve Stimulation (tVNS) | University of Florida, University of Miami, University of Louisville, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Exegi Pharma, LLC, Soterix Medical | Cognition, Gut Microbiome | 06/26 | 06/26 | | |
| Recruiting | N/A | 2000000 | US | Non-interventional (observational only) | Epividian | Chronic Disease, HIV/AIDS, Liver Diseases, Inflammatory Bowel Diseases, Cardiovascular Diseases, Rheumatic Diseases, Neurodegenerative Diseases | 11/27 | 11/27 | | |
NCT03449706: Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection |
|
|
| Recruiting | N/A | 70 | Europe | Early combination anti-retroviral treatment | University Hospital, Ghent, ViiV Healthcare | HIV, Seroconversion, HIV | 01/28 | 01/28 | | |
NCT02390297: Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients |
|
|
| Active, not recruiting | N/A | 11 | US | Blood tests | Calimmune, Inc. | HIV-1 Infection, Receipt of Cal-1 Modified Hematopoietic Cellular Products | 10/31 | 10/31 | | |
NCT04201782: Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T |
|
|
| Terminated | N/A | 38 | US | There are no disallowed treatments | Sangamo Therapeutics | HIV-1-infection | 07/23 | 07/23 | | |
NCT05529342: Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T |
|
|
| Enrolling by invitation | N/A | 7 | US | Gene modified therapy | American Gene Technologies International Inc. | HIV | 05/38 | 09/38 | | |
NCT00404989: Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. |
|
|
| Recruiting | N/A | 24258 | US | | Syneos Health, AbbVie, Alvogen Korea, Amneal Pharmaceuticals, LLC, Apotex Inc., Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Ltd., Dr. Reddy's Laboratories Limited, Gilead Sciences, Hetero Labs, Hikma Pharmaceuticals LLC, i3 Pharmaceuticals, LLC, Janssen Scientific Affairs, LLC, Lannett Company, Inc., Laurus Labs Limited, Lupin Pharmaceuticals, Inc., Macleods Pharmaceuticals Ltd, Merck Sharp & Dohme LLC, Mylan Laboratories, Pharmascience Inc., Qilu Pharmaceutical Co., Ltd., Sigmapharm Laboratories, Strides Shasun Limited, Teva Pharmaceuticals USA, ViiV Healthcare | HIV Infections, Hepatitis B | 01/99 | 01/99 | | |
NCT04605354: Epidemiological and Clinical Description of Women Living With HIV in Selected Countries of Latin America |
|
|
| Enrolling by invitation | N/A | 25816 | RoW | | Helios Salud, ViiV Healthcare | HIV-1-infection, Hiv | 01/22 | 01/22 | | |
NCT05259761: Overcoming Geography With Technology: Medical Drones Project |
|
|
| Recruiting | N/A | 1450 | RoW | Unmanned ariel vehicle | Makerere University, Johnson & Johnson, Rakai Health Sciences Program | Sexually Transmitted Infections (Not HIV or Hepatitis), HIV Infections, COVID-19 | 03/22 | 06/22 | | |
| Active, not recruiting | N/A | 1049 | US | | Mazonson & Santas Inc., Peter Shalit MD and Associates, Red River Family Practice, Central Texas Clinical Research, Rosedale Infectious Diseases, Midland Medical Center, Anthony Mills MD Inc, Stanford University, Whitman-Walker Institute, University of California, San Diego, Ruth M. Rothstein CORE Center, UW Health, ViiV Healthcare | HIV | 10/22 | 10/22 | | |
NCT05692505: Multicenter Performance Study of QuadQuik Invitro Diagnostic Device |
|
|
| Not yet recruiting | N/A | 200 | US | QuadQuik | Genlantis Diagnostics, Ahsan Awan | HIV Infections, Hepatitis C, Hepatitis B, Syphilis Infection | 04/23 | 06/23 | | |